During the past decade, H+ Yangji Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "H+ Yangji Hospital" are "Hypertension" (2 trials), "Anticoagulant" (1 trials), "Embolism and Thrombosis" (1 trials) and "Hyperlipidemias" (1 trials). Many other conditions were trialed in "H+ Yangji Hospital" in a lesser frequency.

Most popular intervention types in "H+ Yangji Hospital" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "AD-221" (1 trials), "AD-221A and AD-221B" (1 trials), "AJU-C52H" (1 trials), "AJU-C52L" (1 trials) and "C52R1H Tab. and C52R2 Tab." (1 trials). Other intervention names were less common.

The vast majority of trials in "H+ Yangji Hospital" are 4 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "H+ Yangji Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in H+ Yangji Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in H+ Yangji Hospital, 5 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".